- Home
- VLRS vs ORGO Comparison
VLRS vs ORGO Comparison
Compare VLRS & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLRS
- ORGO
- Stock Information
- Founded
- VLRS 2005
- ORGO 1985
- Country
- VLRS Mexico
- ORGO United States
- Employees
- VLRS N/A
- ORGO N/A
- Industry
- VLRS Air Freight/Delivery Services
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- VLRS Consumer Discretionary
- ORGO Health Care
- Exchange
- VLRS Nasdaq
- ORGO Nasdaq
- Market Cap
- VLRS 636.8M
- ORGO 665.8M
- IPO Year
- VLRS N/A
- ORGO N/A
- Fundamental
- Price
- VLRS $4.82
- ORGO $3.80
- Analyst Decision
- VLRS Strong Buy
- ORGO Buy
- Analyst Count
- VLRS 7
- ORGO 2
- Target Price
- VLRS $13.00
- ORGO $5.50
- AVG Volume (30 Days)
- VLRS 945.6K
- ORGO 1.2M
- Earning Date
- VLRS 04-22-2025
- ORGO 05-08-2025
- Dividend Yield
- VLRS N/A
- ORGO N/A
- EPS Growth
- VLRS 1492.22
- ORGO N/A
- EPS
- VLRS 0.11
- ORGO N/A
- Revenue
- VLRS $3,142,000,000.00
- ORGO $482,043,000.00
- Revenue This Year
- VLRS $5.25
- ORGO $3.31
- Revenue Next Year
- VLRS $19.50
- ORGO $12.50
- P/E Ratio
- VLRS $4.84
- ORGO N/A
- Revenue Growth
- VLRS N/A
- ORGO 11.29
- 52 Week Low
- VLRS $5.07
- ORGO $2.17
- 52 Week High
- VLRS $9.57
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- VLRS 23.93
- ORGO 38.07
- Support Level
- VLRS $5.07
- ORGO $4.80
- Resistance Level
- VLRS $5.36
- ORGO $4.45
- Average True Range (ATR)
- VLRS 0.19
- ORGO 0.31
- MACD
- VLRS 0.02
- ORGO -0.17
- Stochastic Oscillator
- VLRS 6.88
- ORGO 3.65
About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.
Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central and South America. It currently operates up to 500 average daily flight segments on routes that connect 44 cities in Mexico as well as 22 cities in the United States, four in Central America and two in South America. It uses promotional fares to stimulate demand and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires at the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger revenues and cargo services.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.